1. ASPIRE A multi-centre, randomised, double-blind, placebo-controlled clinical trial examining the efficacy and safety of low-dose aspirin after initial anticoagulation to prevent recurrent venous thromboembolism ctc.usyd.edu.au/our-work/research-divisions/cardiovascular/closed-trials/aspire/
2. ASPIRE. A multi-centre, randomised, double-blind, placebo-controlled clinical trial examining the efficacy and safety of low-dose aspirin after initial anticoagulation to prevent recurrent venous thromboembolism trialsearch.who.int/?trialid=ACTRN12605000004662
3. ASPIRE A multi-centre, randomised, double-blind, placebo-controlled clinical trial examining the efficacy and safety of low-dose aspirin after initial anticoagulation to prevent recurrent venous thromboembolism anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12605000004662
4. Aspirin for the prevention of recurrent venous thromboembolism after a first unprovoked event: results of the ASPIRE randomized controlled trial. In: Late-Breaking Clinical Trial Abstracts;Brighton;Circulation,2012
5. Low-dose aspirin for preventing recurrent venous thromboembolism;Brighton;New England Journal of Medicine,2012